Literature DB >> 7739802

Transfecting neurons and glia in the rat using pH-sensitive immunoliposomes.

E E Geisert1, N A Del Mar, J L Owens, E G Holmberg.   

Abstract

Immunoliposomes were constructed using antibody 5-113 (directed to an antigen on the external surface rat glial cells), the antibody Thy 1.1, and a non-immune antibody. The antibodies were conjugated to N-gluytaryl-phosphatidylethanolamine. Liposomes were constructed with these conjugated antibodies, other lipids and a beta-galactosidase plasmid under the control of the cytomegalovirus promoter. When immunoliposomes decorated with one of three different antibodies were injected into the brain or spinal cord of adult rats, the X-gal reaction product was observed in neurons, astrocytes and vascular elements. There was an increase in neuronal labeling when animals were injected with Thy 1.1 conjugated liposomes and there was an increase in glial labeling in animals injected with 5-113 liposomes. In spinal cords, the immunoliposomes appear to penetrate a substantial distance, transfecting neurons several centimeters from the site of delivery. These data suggest that immunoliposomes may provide an effective transfection system for gene delivery in the CNS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739802     DOI: 10.1016/0304-3940(94)11163-d

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury.

Authors:  Laura De Laporte; Yang Yang; Marina L Zelivyanskaya; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

2.  Uptake of liposomally entrapped adenosine-3'-5'-cyclic monophosphate in mouse brain.

Authors:  Ivone Gomes; Shail K Sharma
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

Review 3.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.